SILVER SPRING, Md., Dec 3 (Reuters) - Swiss drugmaker Novartis AG’s widely-used malaria drug, Coartem, appears safe and effective for use in the United States, a U.S. advisory panel overwhelmingly said on Wednesday.
SILVER SPRING, Md., Dec 3 (Reuters) - Swiss drugmaker Novartis AG’s widely-used malaria drug, Coartem, appears safe and effective for use in the United States, a U.S. advisory panel overwhelmingly said on Wednesday.
